Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorMassachusetts General Hospital

About this trial

The purpose of this quality improvement initiative is to explore whether an electronic medical records-based templated progress note for polycythemia vera (PV) in addition to a standard-of-care pharmacist-collaborative ropeginterferon alfa-2b titration service is feasible, acceptable, and appropriate for clinicians who manage PV.

Eligibility criteria

Qualifiers

None

Disqualifiers

Clinicians who do not have an outpatient hematology or medical oncology clinic within Mass General Brigham.

Clinicians who do not utilize the EPIC electronic medical record (EMR) System as their method of patient progress note documentation.

Trial design

Treatments tested in this trial

  • Standardized progress note

Treatment groups

32 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators